Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

News [7828]

The glucocorticoid receptor is a double-edged sword in prostate cancer

The glucocorticoid receptor is a double-edged sword in prostate cancer

Pancreatic cancer vaccines eliminate disease in preclinical trials

Pancreatic cancer vaccines eliminate disease in preclinical trials

Rare non-small cell lung cancer with brain metastases responds to amivantamab monotherapy

Rare non-small cell lung cancer with brain metastases responds to amivantamab monotherapy

HPV drives tumour development in rare nasal cancers

HPV drives tumour development in rare nasal cancers

Patients are opting in for 10 years of breast cancer treatment

Patients are opting in for 10 years of breast cancer treatment

A study led by CIC bioGUNE delves into the complexity of the most aggressive form of prostate cancer

A study led by CIC bioGUNE delves into the complexity of the most aggressive form of prostate cancer

Genomic abnormalities in T-follicular helper lymphoma and patient outcomes

Genomic abnormalities in T-follicular helper lymphoma and patient outcomes

Pancreatic cancer spreads to liver or lung thanks to this protein

Pancreatic cancer spreads to liver or lung thanks to this protein

ASCO 2025: Experimental Drug Development Centre announces the presentation of updated data from the phase 1 study of antibody-drug conjugate EBC-129 at the 2025 Annual Meeting of the American Society of Clinical Oncology (ASCO)

ASCO 2025: Experimental Drug Development Centre announces the presentation of updated data from the phase 1 study...

New therapy to overcome treatment-resistant skin cancers

New therapy to overcome treatment-resistant skin cancers

More from ecancer